Trending News

Bayer pairs its products in first-ever portfolio T

Bayer is taking on myths about intrauterine devices (IUDs) in a new two-product ad campaign. The fir
Read More

Does Vaccinating Against Rotavirus Also Protect Ag

The rotavirus vaccine may be pulling double duty; it not only protects young children against a pote
Read More

Roche to buy gene therapy firm Spark for $4.8 bill

Roche is to buy gene therapy firm Spark Therapeutics for $4.8 billion, adding an already-approved tr
Read More

Novartis pays $150M to license Akcea-Ionis cardiac

Novartis has taken up its option to license antisense oligonucleotide TQJ230, triggering a $150 mill
Read More

Notable Labs brings on 2 development executives ah

Incyte’s Hiroomi Tada joined as chief medical officer, while Aquinox’s Lloyd Mackenzie will serve as
Read More

Despite Government Shutdown, Exelixis Snags FDA Ap

Shares of Alameda, Calif.-based Exelixis are climbing after the U.S. Food and Drug Administration (F
Read More

OxyContin Maker Sought 'Blizzard of Prescriptions’

The notorious legacy of OxyContin continues to be a major black mark against Purdue Pharma. And that
Read More


;